ArticleScientific reports2026
Unique phenotypic and T cell receptor characteristics of CD8
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Immune-Chemokine Axis in Alzheimer's Disease: Roles of Adaptive Immune System in Neuroinflammation and Disease Progression.Biomolecules · 2026Review
- Neuronal expression of β2M and MHC I are essential for peripheral surveillance and targeting of neuron-restricted antigens.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In Alzheimer’s disease (AD), the involvement of CD8⁺ tissue-resident memory T cells (Trm) have attracted growing interest. During AD pathogenesis, age-associated and AD-associated CD8⁺ T cells may cooperatively influence disease progression; however, their phenotypic and functional differences remain poorly understood. Here, we reanalyzed public single-cell RNA sequencing datasets of brain-derived CD8⁺ T cells from normally aged, wild-type AD, and Cxcr6-deficient AD mice. We identified two major Trm populations: a C-X-C chemokine receptor type 6 (CXCR6)-related immunosuppressive cluster present in aged and wild-type AD mice, and an AD-associated cluster with stem-like features. These clusters were completely phenotypically and clonotypically distinct. Given the proposed role of CXCR6-related CD8⁺ T cells in reducing amyloid-β pathology, their presence in aged mice suggests a protective role. By contrast, the AD-associated cluster exhibited high Tcf7 and Bcl2 expression alongside upregulated immediate-early genes (IEGs), and showed strong clonal overlap with other IEG–enriched clusters. CellChat analysis revealed selective activation of the galectin-9-prolyl 4-hydroxylase pathway in AD-associated Trm-microglia interactions, implicating altered redox regulation. Structural modeling of expanded T cell receptors predicted stable binding to amyloid-β42 peptides, suggesting potential antigen specificity. These findings reveal two transcriptionally and clonotypically distinct CD8+ Trm populations with potentially opposing functions in AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.